Search Results

2018 he joined the University of Copenhagen, where he has received an ERC Starting Grant, Lundbeck Foundation Fellowship, and Novo Nordisk Foundation Ascending Investigator awards.

After working in the US and at the University in Graz in Austria, Maria worked several years at Novo Nordisk before joining InterAx Biotech in Switzerland as their Chief Scientific Officer.

Jacek Mokrosiński "Jacek is a Senior Scientist at Novo Nordisk specializing in molecular pharmacology Since 2021, Jacek has been working at Novo Nordisk at its research sites in the UK (Oxford) and the US Jacek shared his experience of working with Piketa and how he found a job in Seda's lab at Cambridge,

Berchiche is the founder of Dr. My experience in basic research at several universities worldwide and early R&D at Novo Nordisk A/S allowed

This is a rare neurodevelopmental disorder caused by de novo mutations in the GRIN genes that encode

has led to a series of high-profile publications and new intellectual property, and at the Mintaka Foundation for Medical Research with a role as co-founder and Chief Scientific Officer.

GPCR Foundry: Accelerate GPCR Drug Discovery Move from idea to insight—faster, smarter, and with confidence GPCR Foundry? GPCR Foundry? The Dr. GPCR Foundry is a nonprofit platform designed to help biotech leaders accelerate GPCR drug discovery GPCR Foundry?

Master dose-response, binding, kinetics, and foundational models. Driving drug discovery? Master dose-response, binding, kinetics, and foundational models. Driving drug discovery?

See the Signal 🔥 Watch course | Dec 9, 2025 🔥 Watch the AMA Session | Dec 2, 2025 🔥 Watch course | Nov 18, 2025 🔥 Watch course | Nov 11, 2025 🔥 Watch the AMA Session | Sept 18, 2025 🔥 Watch course | Oct 2025 TCBuyCourse Start Learning with Terry Best Value Terry’s Corner $2,999 $ 2,999 Every year Only Founders Explore : Foundational Lessons — Build Your Pharmacology Core Emerging Drug Hunter — Expand Your Edge

He has held four Canada Research Chairs since 2001 and was previously a Heart and Stroke Foundation of Canada MacDonald Scholar (1998-2003) and Heart and Stroke Foundation of Ontario Career Investigator

He has held four Canada Research Chairs since 2001 and was previously a Heart and Stroke Foundation of Canada MacDonald Scholar (1998-2003) and Heart and Stroke Foundation of Ontario Career Investigator

University Vault Premium Pricing GPCR Masterclass YC-Biotech YC-VC YC-CRO Terrys Corner Media Partner Foundry These presentations provide foundational and advanced insights that continue to inform current research

Saraf on the web FRAXA Research Foundation Google Scholar ResearchGate LinkedIn Dr.

During his time at UC San Diego Steve worked directly with the founding Chair of the Nanoengineering Department, Ken Vecchio helping set the foundation for the Nanoengineering Materials Research Center After graduating from UCSD he founded Nanome Inc to build Virtual Reality solutions for Scientists and

She is a National Heart Foundation of Australia Future Leader Fellow and runs a laboratory of 7 Ph.D.

Core Values: The Foundation of Every Successful Partnership My advisory is built on principles that ensure As the founder of Dr.

In 1992, he won a Helen Hay Whitney Foundation fellowship to support his post-doctoral work with Robert

In 1992, he won a Helen Hay Whitney Foundation fellowship to support his post-doctoral work with Robert

In 1992, he won a Helen Hay Whitney Foundation fellowship to support his post-doctoral work with Robert

In 1992, he won a Helen Hay Whitney Foundation fellowship to support his post-doctoral work with Robert

Keck Foundation, and the John J. Abel Award from ASPET .

Explore the Masterclass Pharmacology Foundations Build the essential lens every scientist needs to see Masterclasses cover a variety of track including but not limited to p harmacology foundations, agonists

This week’s feature goes straight to the foundation: how system-level GPCR thinking protects discovery GPCR Read Full Issue Oct 24 - Nov 6, 2025 The Power and Peril of Irreversible Drugs Read Full Issue Oct

Founded in 2020, Dr. Founded in 2020, Dr. What We Do (in Three Verbs) Connect — Researchers, founders, students, and industry partners meet, learn Partner perks: Direct interaction with researchers, founders, and decision‑makers Access to all member & Director Yamina Berchiche Get in touch Co-Founder Attila Foris Get in touch Board Member Anne M.

With a foundational career at Cisbio Bioassays—later acquired by Revvity—Eric played a pivotal role in

These presentations provide foundational and advanced insights that continue to inform current research

GPCR, from its founding to today’s global community, and discover the journey that’s shaping the future Nov 2020 — Invited to the 9th GDR Meeting with Beyond the Lab . 2021 Expanding the Conversation Podcast Nov 2022 — Featured at PhageMed Unige with Leadership Is a Learned Skill . 2023 A Year of Reflection Nov 2023 — Co-organized the 22nd Great Lakes GPCR Retreat 2024 Strengthening Foundations and Expanding

Jean-Philippe Pin on the web LinkedIn ResearchGate CNRS Fondation Bettencourt Schueller FRC Neurodon

Biotech founder Ajay Yekkirala shares how AI, GPCRs, and bold questions are driving next-gen pain therapeutics Ajay Yekkirala is a GPCR pharmacologist, biotech entrepreneur, and co-founder of Superluminal Medicines PhD application rerouted his path toward a breakthrough GPCR research career The inside story behind founding Ajay Yekkirala is a molecular pharmacologist, biotech founder, and scientist whose career has been defined Seeing the limits of traditional drug discovery, he later co-founded Superluminal Medicines, a company

Mike Caterina laid the foundation. But the deeper mission? Underestimated Role of RGS Proteins in Pain Although not a self-proclaimed GPCR specialist, Serafini found “We’re using outdated drugs. There are more elegant GPCR targets waiting to be explored.” him, especially those who shared administrative, grant-writing, and leadership skills early on, he found